Unclaimed Scholar Profile
Are you Gaurav Kwatra? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at South African Medical Research CouncilASIDASID-5977-0520-7653 orcid.org/0009-0008-2032-1975
Gaurav Kwatra
South African Medical Research Council•South Africa
Faculty researcher at South African Medical Research Council (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Neonatal and Maternal Infections#SARS-CoV-2 and COVID-19 Research#Bacterial Infections and Vaccines#Streptococcal Infections and Treatments
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 9,881 | 4,743 |
| h-index | 24 | 18 |
| i10-index | 41 | 29 |
Annual Citation Growth
Verified Citations / Year0
2020474
2021+40%664
2022+29%854
2023+33%1.1k
2024-8%1.0k
2025-45%569
2026Scholarship Distribution & Proportions100 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (8,102) • 18% Global Research Impact (1,779)
100 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (100)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2102214 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Published in Cell•2022
DOI: 10.1016/j.cell.2021.12.046 Verified Peer-Reviewed
Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis
Published in The Lancet Infectious Diseases•2016
DOI: 10.1016/s1473-3099(16)30055-x Verified Peer-Reviewed
Showing 1 – 5 of 100 publications
1 / 20